drugset / Trial / NCT05103397

High Dose Methylprednisolone Verses Low Dose in Correction of Congenital Acynotic Heart Disease

NCT05103397

Phase 4 Unknown 75 enrolled Ain Shams University
RandomizedParallel-groupQuadruple-blindTreatment

Summary

To compare the effect of low dose methylprednisolone versus high dose on inflammatory mediators' level and cardioprotective effect after CPB in correction of congenital acyanotic heart disease.

Timeline

Start
2021-10-16
Primary completion
2022-01-15
Completion
2022-01-30

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methyl Prednisolonate Small molecule 30 mg/kg
Comparator Methylprednisolone Other / unclassified 10 mg/kg

Indications

No indication recorded.